NCT05809830
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05809830
Title Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas (Enhancer)
Acronym Enhancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital de la Santa Creu i Sant Pau Barcelona Catalonia 08026 Spain Details
Hospital Clínico San Carlos Madrid Madrid 28040 Spain Details
Hospital Fundación Jiménez Díaz Madrid Madrid 28040 Spain Details
Hospital Universitario La Paz Madrid Madrid 28046 Spain Details
Hospital Clínico Universitario Virgen de la Arrixaca Murcia Murcia 30120 Spain Details
Hospital Clínico Universitario de Valencia Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field